المؤلفون: Doorduijn, Jeanette, Zijlstra, JM, Lugtenburg, Elly, Kersten, MJ, Bohmer, LH, Minnema, MC, MacKenzie, MA, Kooij, RV, de Jongh, E, Snijders, TJF, de Weerdt, O, Gelder, M, Hoogendoorn, E, Leys, RB, Kibbelaar, RE, Jong, D, Chitu, Dana, van 't Veer, Mars B., Kluin-Nelemans, HC

المصدر: Doorduijn , J , Zijlstra , JM , Lugtenburg , E , Kersten , MJ , Bohmer , LH , Minnema , MC , MacKenzie , MA , Kooij , RV , de Jongh , E , Snijders , TJF , de Weerdt , O , Gelder , M , Hoogendoorn , E , Leys , RB , Kibbelaar , RE , Jong , D , Chitu , D , van 't Veer , M B & Kluin-Nelemans , HC 2020 , ' Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial ' , British Journal of Haematology , vol. 190 , no. 3 , pp. 385-393 .

مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01; name=EMC OR-01, article

URL: https://pure.eur.nl/en/publications/261d5f10-5a78-4fb7-8236-f3d2b505c801

المؤلفون: Chamuleau, ME, Burggraaff, CN, Nijland, M, Bakunina, Katerina, Mous, R, Lugtenburg, Elly, Dierickx, D, van Imhoff, GW, Vermaat, JS, Marijt, EAF, Visser, O, Mandigers, C, Bilgin, YM, Beeker, A, Durian, MF, van Rees, BP, Bohmer, LH, Tick, LW, Boersma, R S, Snijders, TJF, Schouten, HC, Koene, HR, de Jongh, E, Hijmering, N, Diepstra, A, van den Berg, A (Andrea), Arens, AIJ, Huijbregts, J, Hoekstra, O, Zijlstra, JM, Jong, Daniël, Kersten, MJ

المصدر: Chamuleau , ME , Burggraaff , CN , Nijland , M , Bakunina , K , Mous , R , Lugtenburg , E , Dierickx , D , van Imhoff , GW , Vermaat , JS , Marijt , EAF , Visser , O , Mandigers , C , Bilgin , YM , Beeker , A , Durian , MF , van Rees , BP , Bohmer , LH , Tick , LW , Boersma , R S , Snijders , TJF , Schouten , HC , Koene , HR , de Jongh , E , Hijmering , N , Diepstra , A , van den Berg , A , Arens , AIJ , Huijbregts , J , Hoekstra , O , Zijlstra , JM , Jong , D & Kersten , MJ 2020 , ' Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus phaselenalidomide: II HOVON trial results of a multicenter ' , Haematologica , vol. 105 , no. 12 , pp. 2805-2812 .

مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01; name=EMC OR-01, article

URL: https://pure.eur.nl/en/publications/513bd0a2-9c18-4671-ac28-b80a8a8b69f3

المؤلفون: von dem Borne PA; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Kemps-Mols BM; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., van Beek AA; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands., van Lammeren D; Department of Hematology, Haga ziekenhuis, Den Haag, The Netherlands., Tijmensen J; Department of Hematology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Sijs-Szabó A; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Oudshoorn MA; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Marijt WAE; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Tjon JML; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1270-1280. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Cytokine Release Syndrome*/etiology , Cytokine Release Syndrome*/mortality , Cyclophosphamide*/therapeutic use , Hematopoietic Stem Cell Transplantation*/adverse effects , HLA Antigens*/immunology , HLA Antigens*/genetics , Transplantation, Homologous*/adverse effects , Histocompatibility Testing*, Humans ; Male ; Female ; Middle Aged ; Adult ; Incidence ; Retrospective Studies ; Aged ; Young Adult ; Adolescent ; Histocompatibility ; Graft vs Host Disease/etiology ; Transplantation Conditioning/methods ; Immunosuppressive Agents/therapeutic use

المؤلفون: Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Huisman F; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., Meeuwes FO; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., van der Poel MWM; Division of Hematology, Department of Interne Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.

المصدر: Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3619-3628.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/therapy , Lymphoma, T-Cell, Peripheral*/mortality , Lymphoma, T-Cell, Peripheral*/diagnosis , Registries*, Humans ; Netherlands/epidemiology ; Male ; Middle Aged ; Female ; Adult ; Aged ; Treatment Outcome ; Young Adult ; Salvage Therapy ; Aged, 80 and over ; Adolescent ; Neoplasm Recurrence, Local/therapy ; Recurrence

المؤلفون: Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, The Netherlands; Department of Hematology, University Medical Center Groningen, Groningen., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht., Plattel W; Department of Hematology, University Medical Center Groningen, Groningen., Van der Poel MWM; Department of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Böhmer L; Department of Hematology, Haga Hospital, The Hague., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden., Neelis KJ; Department of Radiotherapy, Leiden University Medical Center, Leiden., Crijns APG; Department of Radiotherapy, University Medical Center Groningen, Groningen., Daniëls LA; Department of Radiotherapy, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen. m.nijland@umcg.nl.

المصدر: Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1163-1170. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/diagnosis , Lymphoma, T-Cell, Peripheral*/epidemiology , Lymphoma, T-Cell, Peripheral*/therapy , Immunoblastic Lymphadenopathy* , Lymphoma, Large-Cell, Anaplastic*, Humans ; Male ; Cohort Studies ; Netherlands/epidemiology ; Combined Modality Therapy ; Prognosis

المؤلفون: Koster EAS; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., von dem Borne PA; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Marijt EWA; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Tjon JML; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Snijders TJF; Department of Hematology, Medical Spectrum Twente, Enschede, Netherlands., van Lammeren D; Department of Hematology, HagaZiekenhuis, The Hague, Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.

المصدر: Frontiers in immunology [Front Immunol] 2024 Mar 13; Vol. 15, pp. 1335341. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Leukemia, Myeloid, Acute*/complications , Virus Diseases*/complications, Humans ; T-Lymphocytes ; Lymphocyte Transfusion/adverse effects ; Unrelated Donors

المؤلفون: Koster EAS; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Bonneville EF; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands., Borne PAVD; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Marijt EWA; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Tjon JML; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, Netherlands., van Lammeren D; Department of Hematology, HagaZiekenhuis, The Hague, Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands., Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.

المصدر: Frontiers in immunology [Front Immunol] 2023 Aug 01; Vol. 14, pp. 1208814. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control, Humans ; Kinetics ; CD8-Positive T-Lymphocytes ; CD4-Positive T-Lymphocytes

المؤلفون: van der Zouwen B; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands. bzouwen@gmail.com., Koster EAS; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., von dem Borne PA; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., Oosten LEM; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., Roza-Scholten MWI; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Snijders TJF; Department of Hematology, Medical Spectrum Twente, Enschede, The Netherlands., van Lammeren D; Department of Hematology, HagaZiekenhuis, The Hague, The Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., Marijt WAF; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., Falkenburg JHF; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, C2R, 2300 RC, Leiden, 9600, The Netherlands.

المصدر: Annals of hematology [Ann Hematol] 2023 May; Vol. 102 (5), pp. 1203-1213. Date of Electronic Publication: 2023 Mar 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/complications , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control, Humans ; Retrospective Studies ; Feasibility Studies ; Lymphocyte Transfusion/adverse effects ; T-Lymphocytes ; Acute Disease ; Unrelated Donors ; Chronic Disease ; Recurrence

المؤلفون: Koster EAS; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: e.a.s.koster@lumc.nl., von dem Borne PA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Egmond EHM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Marijt EWA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Veld SAJ; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Jedema I; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., van Lammeren D; Department of Hematology, HagaZiekenhuis, The Hague, The Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Apr; Vol. 29 (4), pp. 268.e1-268.e10. Date of Electronic Publication: 2022 Dec 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/prevention & control , Leukemia*, Humans ; T-Lymphocytes ; Chimerism ; Retrospective Studies ; Transplantation, Homologous ; Lymphocyte Transfusion/methods

المؤلفون: Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, the Netherlands; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Woei-A-Jin S; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Diepstra A; Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.nijland@umcg.nl.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 100-109. Date of Electronic Publication: 2022 Oct 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Lymphoma, Large B-Cell, Diffuse*/pathology , Epstein-Barr Virus Infections* , Lymphoma, T-Cell*/drug therapy, Humans ; Rituximab/therapeutic use ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Transplantation, Autologous ; Herpesvirus 4, Human ; Retrospective Studies ; Neoplasm Recurrence, Local ; Vincristine/therapeutic use ; Cyclophosphamide/therapeutic use ; Prednisone/therapeutic use ; Treatment Outcome ; Doxorubicin/therapeutic use